11. CHARACTERISTICS OF GLOBAR PNEUMONIA AT THE RESPIRATORY DEPARMENT 1 IN CHILDREN’S HOSPITAL 2
Main Article Content
Abstract
Objectives: A survey of the clinical characteristics, paraclinical findings, microbial agents, complications, and the treatment outcomes of the lobar pneumonia at the Respiratory Department 1 in Children’s Hospital 2.
Method: A prospective case series report study.
Results: One hundred- thirty one (131) patients were described.The median age of onset was 5 years. Among the patients with globar pneumonia, 96.9 % had completed the full Hib vaccination schedulem, while 71% had not completed the pneumococcal vaccination. Most patients had normal white blood cell counts and neutrophil percentages in peripheral blood for their age. Elevated CRP levels (>20mg/dl) were found in 61.8% of globar pneumonia cases. On chest X-rays, right lower lobe pneumonia was the most commonly observed. The bacterial causes of globar pneumonia isolated through nasopharyngeal cultures had a low positive rate of 12.2%, with S. aureus being the most commonly identified organism. Other bacteria included H. influenzae and S. pneumoniae. Complications were present in 15.3% of globar pneumoniaa cases, most commonly respiratory failure and sepsis, followed by lung consolidation, pleural empyema and necrosis. A total of 60.5% of cases responded to initial antibiotic treatment, while 39.5% did not respond and required either a change or addition of antibiotics. Among these, Levofloxacin was the most frequently substituted antibiotic (62.2%), which correlated with a 66.4% positive rate for IgM serology diagnostic for Mycoplasma pneumoniae.
Conclusion: Lobar pneumonia is a condition that can cause severe complications, with the leading bacterial pathogens being Staphylococcus aureus and Streptococcus pneumoniae. Therefore, initial antibiotic treatment for lobar pneumonia should cover both of these pathogens.
Article Details
Keywords
globar pneumonia.
References
[1] Bao F, Qu JX, Liu ZJ, Qin XG, Cao B (2013). The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children]. Zhonghua Jie He He Hu Xi Za Zhi;36(10):756-61.
[2] McAllister DA, Liu L, Shi T, Chu Y, Reed C, Burrows J, et al (2019). Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health;7(1):e47-e57.
[3] Tran KQ, Pham VH, Nguyen PM, Tran HD, Lu HQ, La VG, et al (2020). Lobar pneumonia and bacterial pathogens in Vietnamese children. Curr Pediatr Res;24(7):247-53.
[4] Đinh TY (2015). Lâm sàng, cận lâm sàng và kết quả điều trị 63 trường hợp viêm phổi thùy tại Bệnh viện Trẻ em Hải Phòng. Tap Chi Nhi Khoa;8(6):23-9.
[5] Lê THH, Nguyễn TNT (2013). Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và tính nhạy cảm với kháng sinh trong viêm phổi thùy ở trẻ em. Tap Chi Y Hoc Viet Nam;411(2):53-9.
[6] Levine OS, O’Brien KL, Deloria-Knoll M (2012). The Pneumonia etiology research for child health project: a 21st century childhood pneumonia etiology study. Clin Infect Dis. ;54(Suppl 2):S93-s101.
[7] Pio A, Kirkwood BR, Gove S (2010). Avoiding hypothermia, an intervention to prevent morbidity and mortality from pneumonia in young children. Pediatr Infect Dis J;29:153-9.
[8] Liu JR (2012). Clinical analysis of 20 cases with streptococcus pneumoniae necrotizing pneumonia in China. Zhonghua Er Ke Za Zhi;50(6):431-4.
[9] Lin Chao-Jen CP-YHF-L, et al (2006). Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children. Journal of microbiology, immunology, and infection;39(6):489-95.
[10] Đào Minh T (2011). Nghiên cứu biểu hiện lâm sàng và căn nguyên viêm phổi thùy ở trẻ em. Tạp chí Y học quân sự (5):34-8.
[11] Iannini PB (2007). A case series of macrolide treatment faillures in community accquired pneumonia. J Chemother;19(5):536-45.